| Literature DB >> 16469084 |
Ryoko Sakamoto1, Yuko Higashi, Kentaro Mera, Takuro Kanekura, Tamotsu Kanzaki.
Abstract
Leuprorelin acetate, a chemotherapeutic agent used to treat prostate cancer, is a synthetic luteinizing hormone-releasing hormone (LHRH) agonist. We report a 75-year-old man who presented with several large subcutaneous nodules at the site of leuprorelin acetate injections for his prostatic cancer. A biopsy of the nodules disclosed epithelioid granulomatous inflammation and resulted in a diagnosis of drug-induced granulomatous reaction to leuprorelin acetate.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16469084 DOI: 10.1111/j.1346-8138.2006.00008.x
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 4.005